Published on in Vol 9, No 2 (2021): February
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/23548, first published
.
![WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial](https://asset.jmir.pub/assets/147078d18b7590ffd9e8e8fa0da87651.png 480w,https://asset.jmir.pub/assets/147078d18b7590ffd9e8e8fa0da87651.png 960w,https://asset.jmir.pub/assets/147078d18b7590ffd9e8e8fa0da87651.png 1920w,https://asset.jmir.pub/assets/147078d18b7590ffd9e8e8fa0da87651.png 2500w)
There are currently no tweets available for this article within the specified range.